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BKVN is 8.3% the method is also cost-effective. Leflunomide treat-
ment seems to be effective for the clearance of BKVN.
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Background: Intestinal transplantation has emerged as a treat-
ment option for patients with life-threatening intestinal failure.
The most common complication and cause of death is infection.
Objective: To determine the 6 month post-operative incidence of
bloodstream infections (BSI), and to characterize associated risk
factors.
Material and Methods: We performed a retrospective chart review
of all small bowel transplant recipients between 2003 -2007. The
characteristics below were analyzed as potential risk factors for
BSI: colon/liver inclusion, total bilirubin >5, surgical complica-
tions, & acute rejection. Most patients received immunosuppres-
sion with basiliximab, tacrolimus, sirolimus and a prednisone taper.
6 patients received thymoglobulin instead of basiliximab.
Results: Fifty-six patients received an intestinal transplant from
November 2003 to July 2007. Twenty-three were adult (>18
years), and 33 pediatric. Nine adults and 25 children developed
BSI (p=0.006). Twenty-two patients received an isolated intesti-
nal transplant, 16 liver-intestine, 16 multivisceral, and 2 modi-
fied multivisceral. The patient characteristics are listed in table
1. Thirty-four of 56 patients (61%) had at least one episode of BSI.
A total of 85 episodes of BSI were observed, with 65.9% of BSI due
to Gram-positives, 34.1% Gram-negatives and 2.4% fungemia (table
2). The most common isolates were: VRE/non-VRE, Enterobacter,
Klebsiella and coagulase negative Staphylococci. The mean time to
first BSI was 26.4 days. Of 85 BSI episodes, 69 occurred in patients
who received a liver. In these 32 patients, 23 had BSI compared
to 11 of the 24 non-liver patients (p=0.048) (table 3). Of 27 pa-
tients with a total bilirubin >5mg/dL, 21 developed BSI compared
to 9 of the 29 patients with a total bilirubin ≤5mg/dL (p=0.000).
Severn of 11 colon inclusion patients developed BSI compared to
27/45 non-colon inclusion pts (p=ns). Of 21 patients with surgical
complications, 12 developed BSI versus 21 of the 35 patients with-
out complications (p=ns). Nineteen patients had acute rejection.
Twelve of these patients had BSI compared to 23 of the 37 patients
who did not reject (p=ns).
Table 1. Patient characteristics
Total number of patients 56
Adults / Pediatric 23 / 33
Males / Female 32 / 24
Average Age ± SD 18.4±19.8 yrs
Age range 6 months – 62 years
Colon inclusion 11 pts
Liver inclusion 32 pts
Surgical complications (perforation, leak, bleed, abscess) 21
Patients with acute rejection 19 pts
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Organism Overall Colon +/– liver Non-colon +/– liver Liver
(n = 85 episodes) (n = 17 episodes) (n = 68 episodes) (n = 69 episodes)
Gram-positive cocci 56/85 12/17 44/68 49/69
(VRE, CNS, MRSA, MSSA, Strep viridans) (65.9%) (70.6%) (64.7%) (71.0%)
Gram-neg rods (Enterobacter, Klebsiella, 29/85 5/17 24/68 20/69
Pseudomonas, E .coli, Citrobacter, others**) (34.1%) (29.4%) (35.3%) (29.0%)
Candida species 2/85 1/17 1/68 2/69
(C. albicans, C. parapsilosis) (2.4%) (5.9%) (1.5%) (2.9%)
**Burkholderia, Stenotrophomonas, Serratia, Capnocytophaga.
Table 3. Patient variables and incidence of BSI
Variable Number of Number of p value
Pts Pts with BSI
Age (Pediatric vs. Adult) 33 / 23 25/9 0.006
Colon (Inclusion vs. No Inclusion) 11 / 45 7/27 ns
Liver (Inclusion vs. No Inclusion) 32 / 24 23/11 0.048
Total bilirubin at Tx (>5 vs ≤5) 27 / 29 21/9 0.000
Surgical complications (Present vs. Absent) 21 / 35 12/21 ns
Acute rejection (Present vs. Absent) 19 / 37 12/23 ns
Conclusions: BSI are a common complication of intestinal trans-
plant. The incidence appears to be higher in children. It appears
that liver inclusion and preoperative bilirubin >5 are associated
with a higher incidence of BSI. Acute rejection and colon inclusion
do not appear to have an influence on BSI incidence.
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Background: Surveillance bronchoscopy is often performed after
lung transplantation in an attempt to identify acute rejection or in-
fection before signs of disease develop. This practice is not known
to improve outcomes.
Objective: To evaluate the microbiologic yield of surveillance BAL
in lung transplant recipients during the first year post-transplant.
Methods: Medical records for all adults who underwent lung trans-
plantation at Duke University between 01 Jan 2005 and 01 Jan
2007 were reviewed. Surveillance bronchoscopies were performed
1, 3, 6 and 12 months after transplant. If acute rejection was de-
tected, the procedure was repeated monthly until 2 sequential
biopsies were negative. BAL specimens were classified according
to whether the subject had symptoms (i.e. new or worsening dysp-
nea, cough, sputum production, fever, a decrease in lung function,
or chest radiograph changes). The clinical relevance of microor-
ganisms detected by culture, direct fluorescent antibody [DFA] or
stain was determined and all therapeutic interventions recorded.
Results: During the study period 128 transplants (124 double-lung,
3 single-lung, and 1 heart-lung) were performed. The median
(range) subject age was 55 (17-70) years. The most common
conditions necessitating transplant were idiopathic pulmonary hy-
pertension (n=42), COPD (n=36), and cystic fibrosis (n=18). A total
of 630 surveillance BALs were submitted for microbiologic analysis;
28.7% (181/630) were from subjects with documented symptoms.
Most (67.5% [425/630]) surveillance samples grew only oropharyn-
geal flora and 4.9% (31/630) were completely negative. Overall,
27.9% (176/630) of specimens had a potential pathogen detected.
Of the potentially significant organisms identified, bacteria
accounted for 41.4% (72/174), fungi 21.8% (38/174), viruses 21.2%
(37/174), mycobacteria 7.5% (13/174), and PCP 1.1% (2/174).
Multiple pathogens were found in 14 samples. BAL fluid from symp-
tomatic subjects yielded a potential pathogen more often than
